Journal
MOLECULAR PSYCHIATRY
Volume 27, Issue 5, Pages 2492-2501Publisher
SPRINGERNATURE
DOI: 10.1038/s41380-022-01501-1
Keywords
-
Funding
- NIDA Intramural Research Program
- National Institute on Alcohol Abuse and Alcoholism [AA026075]
- NIDA [DA048882, DA043268]
- Canadian Institutes of Health Research fellowship
Ask authors/readers for more resources
This study explores the mechanistic role of extrahypothalamic stress systems in driving opioid addiction and finds that glucocorticoid receptor antagonism with mifepristone reduces opioid addiction-like behaviors and decreases the firing of corticotropin-releasing factor neurons in the rat amygdala.
The global crisis of opioid overdose fatalities has led to an urgent search to discover the neurobiological mechanisms of opioid use disorder (OUD). A driving force for OUD is the dysphoric and emotionally painful state (hyperkatifeia) that is produced during acute and protracted opioid withdrawal. Here, we explored a mechanistic role for extrahypothalamic stress systems in driving opioid addiction. We found that glucocorticoid receptor (GR) antagonism with mifepristone reduced opioid addiction-like behaviors in rats and zebrafish of both sexes and decreased the firing of corticotropin-releasing factor neurons in the rat amygdala (i.e., a marker of brain stress system activation). In support of the hypothesized role of glucocorticoid transcriptional regulation of extrahypothalamic GRs in addiction-like behavior, an intra-amygdala infusion of an antisense oligonucleotide that blocked GR transcriptional activity reduced addiction-like behaviors. Finally, we identified transcriptional adaptations of GR signaling in the amygdala of humans with OUD. Thus, GRs, their coregulators, and downstream systems may represent viable therapeutic targets to treat the stress side of OUD.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available